A comprehensive checklist to ensure compliance with FDA 21 CFR Part 11 regulations for electronic records and electronic signatures in pharmaceutical companies.
FDA 21 CFR Part 11 Compliance Checklist
Get Template
About This Checklist
The FDA 21 CFR Part 11 Compliance Checklist is an essential tool for pharmaceutical companies to ensure their electronic records and electronic signatures meet regulatory requirements. This comprehensive checklist helps organizations navigate the complex landscape of data integrity, system validation, and documentation in the digital age. By addressing key aspects of electronic record-keeping and signature processes, this checklist enables companies to maintain compliance, reduce risks, and streamline their quality management systems.
Learn moreIndustry
Standard
Workspaces
Occupations
Indicate if backup procedures are established.
Select the status of data integrity monitoring tools.
Provide a detailed account of any data integrity issues.
Enter the date of the last data integrity audit.
Enter the frequency of data integrity checks in terms of times per year.
Select compliance status.
Select compliance status with FDA regulations.
Indicate if training is regularly provided.
Provide a detailed description of compliance procedures.
Enter the date of the last compliance review.
Enter the number of compliance violations.
Select if management review has been conducted.
Select the status of the risk assessment for electronic signature use.
Enter the count of identified risks related to electronic records.
Indicate if mitigation plans are in place for identified risks.
Enter the date of the last risk assessment.
Provide a detailed summary of risk mitigation strategies.
Select if the risk management policies have been reviewed.
FAQs
The checklist covers areas such as system validation, audit trails, electronic signatures, access controls, documentation, and data retention policies.
The primary purpose is to ensure that pharmaceutical companies comply with FDA regulations regarding electronic records and electronic signatures, maintaining data integrity and security in their digital systems.
This checklist should be used by quality assurance managers, IT professionals, regulatory affairs specialists, and compliance officers in pharmaceutical companies.
The checklist should be used regularly, typically on a quarterly or semi-annual basis, and whenever significant changes are made to electronic systems or processes.
By regularly using this checklist, companies can maintain comprehensive documentation of their compliance efforts, making it easier to demonstrate adherence to FDA regulations during inspections.
Benefits of FDA 21 CFR Part 11 Compliance Checklist
Ensures compliance with FDA 21 CFR Part 11 regulations
Improves data integrity and security in electronic systems
Facilitates easier audits and inspections
Reduces the risk of regulatory non-compliance and associated penalties
Enhances overall quality management in pharmaceutical operations